Tech Company Financing Transactions
Quotient Biodiagnostics Funding Round
On 3/7/2012, Quotient Biodiagnostics raised $11.2 million in funding from Galen Partners and private investors.
Transaction Overview
Company Name
Announced On
3/7/2012
Transaction Type
Venture Equity
Amount
$11,200,000
Round
Undisclosed
Investors
Galen Partners (Lead Investor) (John Wilkerson)
Proceeds Purpose
The new funds will be used to fund the growth of the Quotient's US commercial operations, to expand the Group's manufacturing and product development operations in Edinburgh, Scotland and to accelerate the development of a next generation automated transfusion diagnostics platform.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
301 South State St. S-204
Newtown, PA 18940
USA
Newtown, PA 18940
USA
Phone
Website
Email Address
Overview
Quotient Biodiagnostics (NASDAQ: QTNT) is focused on providing high quality, high value immunohematology products to hospitals and blood banks in the US.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Cowan
Chief Technical Officer
John Allen
President
Jeremy Stackawitz
VP - Sales
Bill Brady
Browse more venture capital transactions:
Prev: 3/7/2012: BioScale venture capital transaction
Next: 3/8/2012: Metis Secure Solutions venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are derived from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs